Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.02 USD | -6.96% | -13.40% | -11.01% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.01% | 198M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.32% | 22.25B | |
-13.14% | 22.09B | |
-8.10% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- B. Riley Downgrades INmune Bio to Neutral from Buy on Chemistry Manufacturing and Controls-Related FDA Hold, Lowers Price Target to $7 from $14